Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis
Authors
Keywords
-
Journal
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-23
DOI
10.1007/s00787-019-01425-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics
- (2018) Mary Coughlin et al. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
- Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis
- (2018) Marc Krause et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Urgent Need for Optimal Monitoring of Metabolic Adverse Effects in Children and Youngsters Who Take On-label or Off-label Antipsychotic Medication
- (2018) Marc De Hert et al. JAMA Psychiatry
- Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study
- (2017) Robert Goldman et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis
- (2017) Anne Katrine Pagsberg et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia
- (2016) Rebecca C. Harvey et al. CNS DRUGS
- Altering the course of schizophrenia: progress and perspectives
- (2016) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- Long-Term Safety of Paliperidone Extended Release in Adolescents with Schizophrenia: An Open-Label, Flexible Dose Study
- (2015) Adam Savitz et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia
- (2015) Robert L. Findling et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Second-Generation Antipsychotic Use in Children and Adolescents: A Six-Month Prospective Cohort Study in Drug-Naïve Patients
- (2014) Celso Arango et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Ziprasidone in Adolescents with Schizophrenia: Results from a Placebo-Controlled Efficacy and Long-Term Open-Extension Study
- (2013) Robert L. Findling et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia
- (2013) Jon McClellan et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Efficacy and Safety of Quetiapine in Adolescents with Schizophrenia Investigated in a 6-Week, Double-Blind, Placebo-Controlled Trial
- (2012) Robert L. Findling et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A Randomized, Double-Blind Study of Paliperidone Extended-Release in Treatment of Acute Schizophrenia in Adolescents
- (2011) Jaskaran Singh et al. BIOLOGICAL PSYCHIATRY
- Management of Schizophrenia in Children and Adolescents
- (2011) Gabriele Masi et al. DRUGS
- Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo controlled trials and guidelines for clinical practice
- (2011) M. De Hert et al. EUROPEAN PSYCHIATRY
- Effects of age of onset on clinical characteristics in schizophrenia spectrum disorders
- (2010) Yu-Chen Kao et al. BMC Psychiatry
- Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons
- (2010) David Fraguas et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
- (2010) David Moher et al. International Journal of Surgery
- Efficacy, safety and tolerability of two risperidone dosing regimens in adolescent schizophrenia: double-blind study
- (2009) Magali Haas et al. BRITISH JOURNAL OF PSYCHIATRY
- Olanzapine compared to quetiapine in adolescents with a first psychotic episode
- (2009) Celso Arango et al. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY
- Worldwide-Schizophrenia Outpatient Health Outcomes (W-SOHO): baseline characteristics of pan-regional observational data from more than 17,000 patients*
- (2009) J. Karagianis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A 6-Week, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Risperidone in Adolescents with Schizophrenia
- (2009) Magali Haas et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study
- (2008) Linmarie Sikich et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Multiple-Center, Randomized, Double-Blind, Placebo-Controlled Study of Oral Aripiprazole for Treatment of Adolescents With Schizophrenia
- (2008) Robert L. Findling et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Comparative Pilot Study of Second-Generation Antipsychotics in Children and Adolescents with Schizophrenia-Spectrum Disorders
- (2008) Jonathan B. Jensen et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Olanzapine Versus Placebo in Adolescents With Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Trial
- (2008) Ludmila Kryzhanovskaya et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now